# Becotatug Vedotin Plus Cisplatin and Radiotherapy in LA-ESCC

> **NCT07697040** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Hebei Medical University Fourth Hospital** · enrollment: 12 (estimated)

## Conditions studied

- Esophageal Squamous Cell Carcinoma

## Interventions

- **DRUG:** Becotatug Vedotin Combined with Cisplatin and Concurrent Radiotherapy

## Key facts

- **NCT ID:** NCT07697040
- **Lead sponsor:** Hebei Medical University Fourth Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2029-07-01
- **Final completion:** 2029-12-31
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07697040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07697040, "Becotatug Vedotin Plus Cisplatin and Radiotherapy in LA-ESCC". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07697040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*